India reported more than 14 lakh new cancer cases and over 9 lakh deaths due to the disease in 2022, and breast cancer was the most common among women, according to the World Health Organization (WHO).Breast and cervix cancers were the most frequent ones among Indian women, making up close to 27 and 18 per cent of the new cases. Among men cancers of lip, oral cavity, and lung were the most common ones, accounting for 15.6 and 8.5 per cent of the new cases, said the recent report by the International Agency for Research on Cancer (IARC), the cancer arm of WHO.The Director of the Tata Memorial Centre, Sudeep Gupta, said the CAR T-cell therapy is an enormously expensive treatment that is out of the reach of an overwhelming majority of people.“NexCAR19 has been rolled out at approximately one-tenth of the price at which it is available outside India,” he said.IIT Bombay Director Prof Subhasis Chaudhuri said the treatment costs approximately Rs 4 crore abroad.The low-cost CAR T-cell therapy is a huge achievement for our country and cancer patients in India, and it places India firmly on the global map of cell and gene therapy, he said.
Source link
